1-7 of 7
Irina Martynkevich, DSc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognosis in Primary Myelofibrosis Patients According to Cytogenetic and Molecular Testing Results

Liubov Polushkina, Irina Martynkevich, DSc, Vasily Shuvaev, MD, Mikhail Fominykh, MD, Dzhariyat Shikhbabaeva, MD, Ekaterina Motyko, PhD, Lyudmila Martynenko, Natalya Cybakova, PhD, Marina Ivanova, MD PhD, Elena Shabanova, Anastasya Zhernyakova, Alsu Savrilova, Kudrat Abdulkadyrov, Prof., MD PhD
Journal: Blood
Blood (2016) 128 (22): 5467.
https://doi.org/10.1182/blood.V128.22.5467.5467
Published: 2016
Journal Articles

The Devil Is Not As Black As He Is Painted - 3-Year Experience of Treating Newly Diagnosed CML Patients with Imatinib Generics

Vasily Shuvaev, MD, Mikhail Fominykh, MD, Vera Udaleva, MD, Irina I Zotova, MD, Regina Golovchenko, MD PhD, Dzhariyat Shikhbabaeva, MD, Irina Martynkevich, DSc, Lyudmila Martynenko, Marina Ivanova, MD PhD, Natalya Tsybakova, PhD, Ekaterina Motyko, PhD, Lyubov Polushkina, MD, Nadezhda Potikhonova, MD PhD, Sophya Tyranova, MD PhD, Marina Zenina, MD PhD, Kudrat Abdulkadyrov, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5441.
https://doi.org/10.1182/blood.V128.22.5441.5441
Published: 2016
Journal Articles

It Is Safe to Change Horses in the Midstream - 3-Year Experience of Treating CML Patients with Imatinib Generics

Vasily Shuvaev, MD, Mikhail Fominykh, MD, Vera Udaleva, MD, Irina I Zotova, MD, Regina Golovchenko, MD PhD, Dzhariyat Shikhbabaeva, MD, Irina Martynkevich, DSc, Lyudmila Martynenko, Marina Ivanova, MD PhD, Natalya Tsybakova, PhD, Ekaterina Motyko, PhD, Lyubov Polushkina, MD, Nadezhda Potikhonova, MD PhD, Sophya Tyranova, MD PhD, Marina Zenina, MD PhD, Kudrat Abdulkadyrov, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5442.
https://doi.org/10.1182/blood.V128.22.5442.5442
Published: 2016
Journal Articles

Minimal Residual Disease in Multiple Myeloma Patients: Influence on Indicators of Progression Free Survival

Andrei Garifullin, Sergei Voloshin, Irina Martynkevich, DSc, Alexey Kuvshinov, Elizaveta Kleina, Vasily Shuvaev, MD, Kudrat Abdulkadyrov, Prof., MD PhD
Journal: Blood
Blood (2016) 128 (22): 5705.
https://doi.org/10.1182/blood.V128.22.5705.5705
Published: 2016
Journal Articles

Influence of JAK2V617F Allele Burden on Hematological Response in the Treatment of Polycythemia Vera

Dzhariyat Shikhbabaeva, MD, Vasily Shuvaev, MD, Regina Golovchenko, MD PhD, Vera Udaleva, MD, Mikhail Fominykh, MD, Irina I Zotova, MD, Lyubov Polushkina, MD, Irina Martynkevich, DSc, Kudrat Abdulkadyrov, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5475.
https://doi.org/10.1182/blood.V128.22.5475.5475
Published: 2016
Journal Articles

Ibrutinib-Based Therapy in the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia

Alexey Kuvshinov, Sergei Voloshin, Irina Martynkevich, DSc, Ludmila Martynenko, Andrei Garifullin, Elizaveta Kleina, Vasily Shuvaev, MD
Journal: Blood
Blood (2016) 128 (22): 5599.
https://doi.org/10.1182/blood.V128.22.5599.5599
Published: 2016
Journal Articles

Impact of Simultaneous Presence of Additional Chromosome Aberrations and BCR-ABL1 Kinase Domain Mutations on Survival in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

Mikhail Fominykh, MD, Vasily Shuvaev, MD, Irina Martynkevich, DSc, Oleg Shukhov, MD, Ekaterina Chelysheva, MD, Anna G Turkina, Prof., MD, Kudrat Abdulkadyrov, Prof., MD PhD
Journal: Blood
Blood (2016) 128 (22): 5437.
https://doi.org/10.1182/blood.V128.22.5437.5437
Published: 2016